Related Experiment Video
Updated: May 31, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Effect Size of Targeted Temperature Management in Pediatric Patients with Post-Cardiac Arrest Syndrome According to
Takeshi Namba1, Mitsuaki Nishikimi1, Ryo Emoto2
1Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 739-0046, Japan.
Insights
Targeted temperature management (TTM) improves neurological outcomes in pediatric post-cardiac arrest syndrome (PCAS) patients with less severe conditions. TTM did not benefit the most critically ill children.
Area of Science:
- Pediatric critical care medicine
- Cardiovascular research
- Neurology
Background:
- Post-cardiac arrest syndrome (PCAS) in children presents significant challenges.
- Differential effects of targeted temperature management (TTM) based on severity are not well understood.
- A novel risk classification tool, rCAST, was developed to stratify PCAS severity.
Purpose of the Study:
- To evaluate the differential effects of TTM in pediatric PCAS patients.
- To assess TTM efficacy across varying severity levels defined by the rCAST score.
- To identify subgroups of pediatric PCAS patients who benefit most from TTM.
Main Methods:
- Analysis of a nationwide prospective registry of out-of-hospital cardiac arrest (OHCA) patients in Japan.
- Pediatric PCAS patients (≤18 years) were stratified into quintiles using the rCAST score.
- TTM's impact on neurological outcomes (CPC/PCPC ≤2 at 30 days) was assessed, with propensity score analysis for specific subgroups.
Main Results:
- 307 pediatric PCAS patients were analyzed from 1526 OHCA cases.
- No good neurological outcome was observed in the highest severity quintile (rCAST ≥18.5), irrespective of TTM.
- TTM was significantly associated with good neurological outcomes in patients with rCAST scores ≤18.0 (OR 1.21, p=0.014).
Conclusions:
- Targeted temperature management (TTM) demonstrates significant benefit for pediatric post-cardiac arrest syndrome (PCAS) patients with less severe conditions (rCAST ≤18.0).
- TTM offers no discernible neurological outcome improvement for the most severely affected pediatric PCAS patients.
- The rCAST tool aids in stratifying risk and guiding TTM decisions in pediatric PCAS.
Aim:
Few studies have investigated the differential effects of targeted temperature management (TTM) according to the severity of the condition in pediatric patients with post-cardiac arrest syndrome (PCAS). This study was aimed at evaluating the differential effects of TTM in pediatric patients with PCAS according to a risk classification tool developed by us, the rCAST.
Methods:
We used data from a nationwide prospective registry for out-of-hospital cardiac arrest (OHCA) patients in Japan. We classified eligible pediatric PCAS patients (aged ≤ 18 years) into quintiles based on their rCAST scores and evaluated the effect of TTM on the neurological outcomes in each severity group. Then, focusing on the severity group that appeared to benefit from TTM, we also evaluated the effect of TTM by propensity score analysis. Good neurological outcome was defined as a score on the Cerebral Performance Category or Pediatric Cerebral Performance Category scale of ≤2 at 30 days.
Results:
Among 1526 OHCA pediatric patients enrolled in the registry, the data of 307 PCAS patients were analyzed. None of the patients in the fifth quintile (rCAST ≥ 18.5) showed a good neurological outcome, regardless of whether they received TTM or not (0% [0/20] vs. 0% [0/73]). The propensity score analysis showed that TTM was significantly associated with a good neurological outcome in patients with rCAST scores in the first to fourth quintile (odds ratio: 1.21 [1.04-1.40], p = 0.014).
Conclusions:
TTM was significantly associated with good neurological outcomes in pediatric PCAS patients with rCAST scores of ≤18.0.
More Related Videos
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
05:00Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
Published on: March 3, 2021
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Decreased Body Temperature
Factors Affecting Body Temperature
Factors may include:
Increased Body Temperature